Aerpio Pharmaceuticals’ Merger with Aadi Bioscience

Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals and Aadi Bioscience announced their entry into a definitive merger agreement.

Aerpio, a biopharmaceutical company focused on developing compounds that activate Tie2, and Aadi Biosciences, a biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, will form a public company that will focus on advancing Aadi’s lead product candidate FYARROTM. Following the proposed merger, Aerpio will change its name to “Aadi Bioscience.”

In support of the merger, Aerpio has entered into subscription agreements to raise $155 million in a Private Investment in Public Equity (PIPE) financing. The PIPE financing is expected to be consummated concurrently with the closing of the merger.

The Wilson Sonsini team advising Aadi included: Dan Koeppen (Picture), Kassandra Castillo, Melissa Freidenreich, Bridget Balisy,  Ethan Lutske, Gwen Karanadze, David Lee, Miranda Biven, John Krocak, Colin Bosch, Shefali Tandon, Tony Nguyen, Brandon Gantus, Matt Norgard, Christopher Williams, Myra Sutanto Shen, Nika Antonikova, David Hoffmeister, Eva Yin, Ryan Greecher and Brian Currie.

The Goodwin team included Danielle Lauzon, Andrew Goodman, James Xu, Tevia Pollard, Karin Yoo, and Sebastien Miao (Corporate, Public M&A), Janet Andolina (Tax), and Sarah Bock (ERISA & Executive Compensation).

Involved fees earner: Janet Andolina – Goodwin Procter; Sarah Bock – Goodwin Procter; Andrew Goodman – Goodwin Procter; Danielle Lauzon – Goodwin Procter; Tevia Pollard – Goodwin Procter; James Xu – Goodwin Procter; Karin Yoo – Goodwin Procter; Bridget Balisy – Wilson Sonsini Goodrich & Rosati; Miranda Biven – Wilson Sonsini Goodrich & Rosati; Colin Bosch – Wilson Sonsini Goodrich & Rosati; Kassandra Castillo – Wilson Sonsini Goodrich & Rosati; Brian Currie – Wilson Sonsini Goodrich & Rosati; Brandon Gantus – Wilson Sonsini Goodrich & Rosati; Ryan Greecher – Wilson Sonsini Goodrich & Rosati; David Hoffmeister – Wilson Sonsini Goodrich & Rosati; Gwen Karanadze – Wilson Sonsini Goodrich & Rosati; Dan Koeppen – Wilson Sonsini Goodrich & Rosati; Ethan Lutske – Wilson Sonsini Goodrich & Rosati; Anthony Nguyen – Wilson Sonsini Goodrich & Rosati; Matthew Norgard – Wilson Sonsini Goodrich & Rosati; David Seoho Lee – Wilson Sonsini Goodrich & Rosati; Myra Sutanto Shen – Wilson Sonsini Goodrich & Rosati; Shefali Tandon – Wilson Sonsini Goodrich & Rosati; Christopher Williams – Wilson Sonsini Goodrich & Rosati; Eva Yin – Wilson Sonsini Goodrich & Rosati;

Law Firms: Goodwin Procter; Wilson Sonsini Goodrich & Rosati;

Clients: Aadi Bioscience; Aerpio Pharmaceuticals, Inc.;

Author: Martina Bellini